The peptide world has a trust problem. Screenshots instead of studies. “Clinically proven” with no clinic in sight. Lab reports that look a little too clean. If you’ve spent five minutes in this space, you’ve seen it.
So here’s how we do things at Ghost Pulse, and why. No hype, no hand-waving. Just the research, the history behind it, and the fine print, out in the open.
A Century of Serious Peptide Science
Peptides aren’t a trend. They’re one of the most rigorously studied areas in modern science, and the history proves it:
- 1921–1922: Insulin. Frederick Banting and Charles Best isolated insulin at the University of Toronto, and in January 1922 it was first given to a patient, a 14-year-old boy named Leonard Thompson. Insulin is a peptide hormone, and its discovery changed medicine forever.
- 1953: The first synthetic peptide hormone. Vincent du Vigneaud’s team synthesized oxytocin in the lab, the first time a peptide hormone had ever been built from scratch. It earned him the 1955 Nobel Prize in Chemistry.
- 1963: Solid-phase peptide synthesis. R. Bruce Merrifield invented a method for building peptides one amino acid at a time on a solid support. It made peptide research faster and more reproducible, and won him the 1984 Nobel Prize in Chemistry. Labs still use versions of it today.
Notice the pattern: decades of careful work, published methods, peer review, and Nobel-level scrutiny. That’s the standard the science was built on, and it’s the standard we hold our content to.
Why “Promising” Isn’t the Same as “Proven”
Here’s a number that should humble anyone who writes about research: roughly 90% of drug candidates that enter human clinical trials fail, according to a widely cited 2022 analysis in Acta Pharmaceutica Sinica B. And those are compounds that already looked good enough in earlier lab and animal work to make it that far.
Translation: a great result in a petri dish or a rat is a starting point, not a finish line. That’s why every Ghost Pulse breakdown tells you exactly what kind of study you’re looking at.
Our Research Standards
Every post in the Ghost Pulse Research Journal follows the same rules:
- Primary sources only. We cite the actual published studies (PubMed, peer-reviewed journals), not blogs, forums or vendor marketing, and we link every one so you can check our work.
- We label the model. Cell culture, animal or human? We say it plainly, every time. A rat study is a rat study.
- We report what was measured. Not what we wish had been measured. If a study looked at tendon strength in rats, that’s what we tell you.
- We name the limitations. Small sample sizes, a single research group, no independent replication: if it matters, it goes in the fine print.
- No dosing, no human-use guidance. We break down research. We don’t tell anyone what to put in their body.
- Corrections in the open. If we get something wrong, we fix it and note the date of the update on the post.
Want to see it in action? Check out our breakdown of the BPC-157 Achilles tendon rat studies: real studies, real methods, real limitations.
How to Read Any Peptide Claim (Ours Included)
Don’t just trust us. Run every claim you see, anywhere, through these five questions:
- Who studied it? One lab, or several independent groups?
- Studied in what? Cells, animals or humans?
- How many? Ten rats and ten thousand people are very different evidence.
- Where was it published? A peer-reviewed journal, or a sales page?
- Does the claim match the data? “Improved tendon healing in rats” is not the same as “heals your injuries.”
If a claim can’t survive those five questions, it doesn’t deserve your trust.
Transparency Is the Whole Point
Ghost Pulse is a research brand. Our products are sold strictly for in vitro and laboratory research, and our content exists to explain published science clearly and honestly. That means showing our sources, admitting what isn’t known yet, and never dressing up early data as a sure thing.
Science earned its credibility the slow way. We intend to do the same.
Follow @ghostpulse_io on TikTok, X & Instagram for more research breakdowns & cheeky content.
References
- University of Toronto Libraries. The Discovery and Early Development of Insulin. Source
- The Nobel Prize in Chemistry 1955: Vincent du Vigneaud. NobelPrize.org. Source
- R. Bruce Merrifield, 1984 Nobel Prize in Chemistry. The Rockefeller University. Source
- Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022;12(7):3049–3062. PubMed Central
Disclaimer: Not Medical Advice. This article is for educational and informational purposes only and is not medical advice. All information is based on publicly available historical records and peer-reviewed scientific publications, linked in the references above. Consult a qualified healthcare professional for any medical questions.
Research Use Only. Products sold by Ghost Pulse are intended for in vitro and laboratory research only and are not for human or veterinary use. They are not intended to diagnose, treat, cure, or prevent any disease.